×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Hemispherx secures replacement for blood cell supplier BioLife
biopharma-reporter.com
Hemispherx has signed supply deals with US blood centres to address supply issues that delayed relaunch of genital wart drug, Alferon.
105 months ago
Hemispherx Updates The Status Of The Alferon Manufacturing Facility
BioSpace
Published: Jul 11, 2016. PHILADELPHIA, July 11, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) in response to various questions about the...
94 months ago
Coronavirus Infection Market Trends and Regional Analysis | AstraZeneca Plc, Hemispherx Biopharma Inc., Humabs ...
Motions Online
You can get the “Coronavirus Infection Market 2024” research study from OrbisResearch.com. Beyond offering Coronavirus Infection market...
3 weeks ago